pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
pharmadog news

Browse

1,890 stories matching this filter · ← front page

★ save view↓export CSV
rangeto
sort
recentoldestsourcealpha
source
STAT1179Endpoints898BioPharma Dive345BioSpace316Fierce Biotech297onclive165raps106globenewswire health
therapy area
allOncology7724Rare Disease1882Cardiology1755Immunology1504Hematology1327Vaccines1202Pulmonology
  • Republican pushback on methadone and buprenorphine raises concerns among addiction experts
    Recent guidance from the Trump administration has revived a debate over the use of methadone and buprenorphine for opioid addiction treatment, prompting renewed scrutiny of federal policy. Addicti…
    STAT · 3mo agoRegulatoryNegative↗ source
  • DOJ announces second settlement on youth gender-affirming care amid broader health news
    The Department of Justice disclosed that it has reached a second settlement with parties involved in providing gender-affirming care to minors. The agreement, announced in a recent newsletter, buil…
    STAT · 3mo agoRegulatoryNeutral↗ source
← prev
page 53 of 76
next →
73
fda recalls70
fda medwatch60
fda press38
1197
Psychiatry & CNS868
Ophthalmology499
Pain480
Endocrinology & Metabolism477
Infectious Disease444
  • ADA CEO apologizes for expelling five members over protest literature, vows review and trust rebuilding
    Five members of the American Diabetes Association were removed from its annual scientific sessions in New Orleans after distributing editorial material that criticized federal research funding cuts…
    STAT · 3mo agoNegative↗ source
  • ACOG issues new pregnancy vaccine schedule that diverges from CDC guidance
    The American College of Obstetricians and Gynecologists (ACOG) released a new vaccine schedule for pregnant individuals that differs from the current CDC guidance. ACOG recommends four vaccines be…
    STAT · 3mo agoNeutral↗ source
  • Nevada Supreme Court blocks enforcement of teen abortion notification law, expanding access
    The Nevada Supreme Court issued a unanimous order on May 28 that temporarily halts the enforcement of the state’s 1985 parental notification requirement for abortions. The preliminary injunction al…
    STAT · 3mo agoRegulatoryPositive↗ source
  • AI sepsis tools face timing challenges, says STAT AI Prognosis newsletter
    The latest STAT AI Prognosis newsletter notes that current sepsis detection algorithms sometimes require data from future time points, which is unrealistic. The piece highlights how such quirks in…
    STAT · 3mo agoNeutral↗ source
  • Septuagenarian begins family-medicine residency at 72 after 45-year nursing career
    Dawn Zuidgeest-Craft, a former neonatal nurse practitioner, finally entered medical school at age 69 after decades of clinical work and personal life events. She graduated in 2025 and, despite not…
    STAT · 3mo agoPositive↗ source
  • Ending federally funded animal testing could stall xenotransplantation breakthroughs
    Transplant surgeon Joshua Mezrich argues that recent moves to end federally funded animal testing could impede the development of xenotransplantation, a field that aims to use pig organs for human…
    STAT · 3mo agoRegulatoryNegative↗ source
  • GSK to acquire cancer-focused biotech Nuvalent for $10.6 billion
    GSK announced it will acquire Nuvalent, a biotech that develops targeted cancer therapies, in a transaction valued at $10.6 billion. The purchase price translates to $124 per Nuvalent share, a 26%…
    STAT · 3mo agoDealPositive↗ source
  • U.S. drug shortages drop 23% but average duration climbs to over five years, analysis shows
    The latest U.S. Pharmacopeia analysis reports that the total number of prescription drug shortages fell by 23% last year, marking the second year of decline and the lowest level since 2017. Despit…
    STAT · 3mo agoNegative↗ source
  • Trump’s health-care affordability czar targets hospitals, raises concerns over suppressed alcohol study
    The piece reports that the Trump administration’s health‑care affordability czar has begun scrutinizing hospitals, signaling a new push to control costs and improve price transparency. The czar’s…
    STAT · 3mo agoRegulatoryNegative↗ source
  • FDA approves first new sunscreen ingredient in over 25 years
    The U.S. Food and Drug Administration has cleared a new sunscreen active called bemotrizinol, the first novel ingredient to receive approval in more than a quarter‑century. The agency said the che…
    STAT · 3mo agoRegulatoryPositive↗ source
  • GSK to acquire Nuvalent for $10.6 billion, expanding its lung-cancer pipeline
    GSK announced it will buy Cambridge-based biotech Nuvalent for $10.6 billion, paying $124 per share, a 26% premium to the biotech's recent average share price. Nuvalent has two lung‑cancer drugs u…
    STAT · 3mo agoDealNeutral↗ source
  • GSK to acquire cancer drug developer Nuvalent for $10.6 billion
    GSK announced an agreement to purchase Nuvalent, a company focused on cancer therapies, in a transaction valued at $10.6 billion. The acquisition is intended to broaden GSK’s oncology portfolio an…
    STAT · 3mo agoDealNeutral↗ source
  • Dexcom trial shows continuous glucose monitors improve outcomes across diabetes types
    Dexcom reported results from a randomized controlled trial that evaluated its continuous glucose monitoring system in a wide range of people with diabetes. The study compared the CGM device to stan…
    STAT · 3mo agoPositive readoutPositive↗ source
  • Trump health-care czar touts $510 billion Medicaid cut, warns hospitals of financial strain
    At a Healthcare Financial Management Association conference in National Harbor, Maryland, the Trump administration’s newly appointed health-care affordability czar addressed hospital finance leader…
    STAT · 3mo agoRegulatoryNegative↗ source
  • Former USAID Ebola adviser says lessons from 2014 are fading as new outbreak spreads in DRC and Uganda
    In October 2014 Susan Reichle served as a counselor to USAID in Washington, D.C., when the CDC launched its largest ever Ebola response. She contrasts that crisis with the current outbreak in the…
    STAT · 3mo agoNeutral↗ source
  • ADA ejects five diabetes experts for distributing editorial criticizing NIH research cuts
    Security personnel removed five diabetes researchers from the American Diabetes Association's annual meeting in New Orleans after they handed out copies of an editorial that condemned recent federa…
    STAT · 3mo agoNegative↗ source
  • Federal alcohol study finds low-level drinking may raise disease risk, faces political pushback
    STAT’s Morning Rounds reported that a federally commissioned study on alcohol’s health effects was published today in an independent journal. The researchers concluded that even modest alcohol cons…
    STAT · 3mo agoRegulatoryNeutral↗ source
  • Trump administration threatens fines for over 500 hospitals that fail to disclose pricing
    The Trump administration has warned more than 500 hospitals that they are not providing the public with basic pricing information, the Associated Press reported. Hospitals that fail to create a pl…
    STAT · 3mo agoRegulatoryNegative↗ source
  • NIH names John Powers III as acting director of NIAID amid leadership uncertainty
    The National Institutes of Health has appointed researcher John Powers III to serve as acting director of the National Institute of Allergy and Infectious Diseases (NIAID). Powers previously served…
    STAT · 3mo agoNeutral↗ source
  • Oura and Whoop add in-app virtual doctor visits, moving wearable data toward clinical use
    Wearable makers Oura and Whoop announced that users will soon be able to connect with doctors through their apps, allowing virtual consultations when a device flags a health concern. The new featu…
    STAT · 3mo agoNeutral↗ source
  • Trump-suppressed alcohol health study released, finds low-level drinking may raise disease risk
    A federal study on alcohol's health effects, commissioned by SAMHSA in 2023 to inform U.S. dietary guidelines, has finally been published in a scientific journal after being withheld by the Trump a…
    STAT · 3mo agoRegulatoryNegative↗ source
  • NIH staff say leadership ignored dissent letter a year after Bethesda Declaration
    A new report released on the one‑year anniversary of the Bethesda Declaration says NIH leadership has largely ignored the concerns raised by staff in their open letter of dissent. The report, titl…
    STAT · 3mo agoNegative↗ source
  • STAT chooses to keep health care as two words despite AP stylebook shift
    The Associated Press updated its style guide in April, merging health care into the single word healthcare. The change sparked discussion among journalists and readers. At STAT, the editorial staf…
    STAT · 3mo agoNeutral↗ source